Biogen inks Alzheimer's deal with Eisai By: Boston Business Journal via Business Journals March 05, 2014 at 09:53 AM EST Biogen Idec has entered into a deal to co-develop potential drugs for Alzheimer’s disease with Japanese drug maker Eisai Co... Read More >> Related Stocks: Pfizer